Laboratory Corporation Of America Holdings (LH) |
|
|
|
Laboratory Of America Holdings Income Statement Quarterly
LH
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
Total Revenue |
4,056.10 |
4,062.60 |
3,840.70 |
4,161.50 |
4,489.80 |
Cost of Revenue |
2,681.10 |
2,677.10 |
2,575.90 |
2,562.50 |
2,584.90 |
Gross
Profit |
1,375.00 |
1,385.50 |
1,264.80 |
1,599.00 |
1,904.90 |
Selling, Administration, Marketing |
543.70 |
519.90 |
458.70 |
429.80 |
518.00 |
Depriciation & Amortization |
92.90 |
92.20 |
92.40 |
92.10 |
90.80 |
Research & development |
- |
- |
- |
- |
- |
Goodwill and Intangible Asset Impairment |
- |
- |
- |
- |
1.20 |
Other operatinig exp. /-income |
- |
- |
0.00 |
- |
0.00 |
Unusual Income/ -Expense |
- |
- |
- |
- |
- |
Net Restructuring And Other Special Charges |
7.80 |
6.50 |
9.60 |
19.20 |
1.70 |
Total operating costs including COS |
3,325.50 |
3,295.70 |
3,136.60 |
3,103.60 |
3,196.60 |
Operating income/-loss
|
730.60 |
766.90 |
704.10 |
1,057.90 |
1,293.20 |
Other Deductions / - Income |
Interest expense |
43.10 |
42.20 |
78.30 |
48.50 |
48.30 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
43.10 |
42.20 |
78.30 |
48.50 |
48.30 |
Loss/ -Gain on Investment |
-7.50 |
-11.60 |
-10.70 |
-6.90 |
15.90 |
Sale of Business |
- |
- |
- |
- |
- |
Sale of Assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
9.00 |
-31.90 |
-14.10 |
-5.50 |
-13.70 |
Total costs & expenses |
3,370.10 |
3,294.40 |
3,190.10 |
3,139.70 |
3,247.10 |
Income /-loss before income taxes |
686.00 |
768.20 |
650.60 |
1,021.80 |
1,242.70 |
Income taxes expenses/-benefit |
132.40 |
180.40 |
182.60 |
251.70 |
304.10 |
Income after income taxes |
553.60 |
587.80 |
468.00 |
770.10 |
938.60 |
Net income/-loss
of other equity |
- |
0.00 |
- |
0.00 |
- |
Income/-loss
from cont. Ops. |
553.60 |
587.80 |
468.00 |
770.10 |
938.60 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
553.60 |
587.80 |
468.00 |
770.10 |
938.60 |
Noncontrolling interests |
-1.60 |
0.50 |
-0.60 |
-0.50 |
1.50 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
553.00 |
587.30 |
467.40 |
769.60 |
938.30 |
EBIT |
729.10 |
810.40 |
728.90 |
1,070.30 |
1,291.00 |
EBITD |
917.10 |
996.50 |
916.00 |
1,254.20 |
1,474.90 |
EBITDA |
917.10 |
996.50 |
916.00 |
1,254.20 |
1,474.90 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
Basic EPS (excl. extra
items) |
-18.78 |
6.10 |
4.80 |
7.88 |
-6.33 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
-18.78 |
6.10 |
4.80 |
7.88 |
-6.33 |
Basic shares outstanding (Mill.
of Units) |
0.00 |
96.28 |
97.38 |
97.66 |
0.00 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
-18.63 |
6.05 |
4.76 |
7.82 |
-6.27 |
Diluted average shares (Mill.
of Units) |
0.00 |
97.07 |
98.19 |
98.41 |
0.00 |
Dividend per share |
- |
- |
- |
- |
- |
|
|